Biotechnology Industry Organization Joins as Sponsor of National Congress on the Future of Pharmaceuticals in Medical Care.WASHINGTON, D.C.--(BUSINESS WIRE)--Nov. 2, 1999-- The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
The congress will be held December 8-10, 1999, at the Hyatt Regency Crystal City in Arlington, Virginia, immediately adjacent the Ronald Reagan National Airport. At a time of great political unrest regarding the costs and coverage of pharmaceuticals, the congress will provide both a policy and practical overview of the role that pharmaceuticals play in America's healthcare financing and delivery system. The nation's leading thinkers on pharmaceutical policy will speak to these issues. Plenary session Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance. These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery. speakers include: - Alan Holmer, President, Pharmaceutical Research and Manufacturers of America Pharmaceutical Research and Manufacturers of America (PhRMA) is an industry trade group representing the pharmaceutical research and biotechnology companies in the United States. - Karen Williams, President, National Pharmaceutical Council - Mary Jane England, M.D., President, Washington Business Group on Health - Karen Ignagni, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , American Association of Health Plans - Reed Tuckson, M.D., Senior Vice President for Professional Standards American Medical Association American Medical Association (AMA), professional physicians' organization (founded 1847). Its goals are to protect the interests of American physicians, advance public health, and support the growth of medical science. - Samuel Thier, M.D., President and CEO, Partners Health Care System, Inc. - Stuart Altman, Ph.D., Sol C. Chaikin Professor of National Health Policy Institute of Health Policy, Heller Graduate School, Brandeis University - Professor Uwe Reinhardt, Ph.D., James Madison Professor of Political Economy Princeton University For other information regarding the Congress, please contact Barrie Handy at 206/628-7405. To register call 888/571-6063. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion